OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 126
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 126
Showing 1-25 of 126 citing articles:
Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders
Carlos Roncero, Bárbara Buch-Vicente, Ángel Manuel Martín-Sánchez, et al.
Gastroenterología y Hepatología (2022) Vol. 46, Iss. 3, pp. 171-177
Open Access | Times Cited: 228
Carlos Roncero, Bárbara Buch-Vicente, Ángel Manuel Martín-Sánchez, et al.
Gastroenterología y Hepatología (2022) Vol. 46, Iss. 3, pp. 171-177
Open Access | Times Cited: 228
Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 24
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1105-1112
Open Access | Times Cited: 24
Silymarin as a Therapeutic Agent for Hepatocellular Carcinoma: A Multi-Approach Computational Study
Ouided Benslama, Sabrina Lekmine, Hamza Moussa, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 53-53
Open Access | Times Cited: 1
Ouided Benslama, Sabrina Lekmine, Hamza Moussa, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 53-53
Open Access | Times Cited: 1
Antioxidant Role of Kaempferol in Prevention of Hepatocellular Carcinoma
Nidhi Sharma, Subhrajit Biswas, Noura Al‐Dayan, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 87
Nidhi Sharma, Subhrajit Biswas, Noura Al‐Dayan, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1419-1419
Open Access | Times Cited: 87
Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 64
Khaled Y. Mahmoud, Shady A. Swidan, Mohamed A. El-Nabarawi, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 64
Immune checkpoint inhibitors in HCC: Cellular, molecular and systemic data
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 53
Uasim Harkus, Miriam Wankell, Pranavan Palamuthusingam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 799-815
Closed Access | Times Cited: 53
Therapeutic options in hepatocellular carcinoma: a comprehensive review
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 1901-1916
Open Access | Times Cited: 36
Diwakar Suresh, Akshatha N. Srinivas, Akila Prashant, et al.
Clinical and Experimental Medicine (2023) Vol. 23, Iss. 6, pp. 1901-1916
Open Access | Times Cited: 36
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Masahito Nakano, Hiroshi Yatsuhashi, Shigemune Bekki, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 28
Hepatitis B virus‐related hepatocellular carcinoma exhibits distinct intratumoral microbiota and immune microenvironment signatures
Yuanjie Liu, Elena S. Kim, Haitao Guo
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 7
Yuanjie Liu, Elena S. Kim, Haitao Guo
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 7
Proanthocyanidins-Based Synbiotics as a Novel Strategy for Nonalcoholic Fatty Liver Disease (NAFLD) Risk Reduction
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Wasitha P. D. W. Thilakarathna, H.P. Vasantha Rupasinghe
Molecules (2024) Vol. 29, Iss. 3, pp. 709-709
Open Access | Times Cited: 5
Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
Chunye Zhang, Shuai Liu, Ming Yang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 35
Chunye Zhang, Shuai Liu, Ming Yang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 35
New understanding of Angelica sinensis polysaccharide improving fatty liver: The dual inhibition of lipid synthesis and CD36-mediated lipid uptake and the regulation of alcohol metabolism
Zihao He, Tingting Guo, Zheng Cui, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 813-825
Closed Access | Times Cited: 23
Zihao He, Tingting Guo, Zheng Cui, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 813-825
Closed Access | Times Cited: 23
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma—A Narrative Review
Shadi Chamseddine, Michael LaPelusa, Ahmed O. Kaseb
Cancers (2023) Vol. 15, Iss. 13, pp. 3508-3508
Open Access | Times Cited: 14
Shadi Chamseddine, Michael LaPelusa, Ahmed O. Kaseb
Cancers (2023) Vol. 15, Iss. 13, pp. 3508-3508
Open Access | Times Cited: 14
Dimethyl fumarate‐mediated Nrf2/ARE pathway activation and glibenclamide‐mediated NLRP3 inflammasome cascade inhibition alleviate type II diabetes‐associated fatty liver in rats by mitigating oxidative stress and inflammation
Durgesh Kumar Dwivedi, Gopabandhu Jena
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 13
Durgesh Kumar Dwivedi, Gopabandhu Jena
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 7
Closed Access | Times Cited: 13
Therapeutic potential of kakkatin derivatives against hepatocellular carcinoma
Sandeep K. Chahal, Vikram Patial
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Sandeep K. Chahal, Vikram Patial
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 3
Closed Access
Personalized Immunity: Neoantigen-Based Vaccines Revolutionizing Hepatocellular Carcinoma Treatment
Ιωάννα Αγγελετοπούλου, Spyridon Pantzios, Christos Triantos
Cancers (2025) Vol. 17, Iss. 3, pp. 376-376
Open Access
Ιωάννα Αγγελετοπούλου, Spyridon Pantzios, Christos Triantos
Cancers (2025) Vol. 17, Iss. 3, pp. 376-376
Open Access
Molecular Approaches based on Investigating the therapeutic Benefits of Moringa Oleifera: Insights into Biochemical and Spermatological and metabolites studies
S. H. Harsha Sankar, Subramaniam Umavathi, Ekambaram Gayathiri, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100065-100065
Open Access
S. H. Harsha Sankar, Subramaniam Umavathi, Ekambaram Gayathiri, et al.
Aspects of Molecular Medicine (2025) Vol. 5, pp. 100065-100065
Open Access
Overview of the hazardous impacts of metabolism-disrupting chemicals on the progression of fatty liver diseases
G.-H. An, Jinyeop Song, Wei Ying, et al.
Molecular & Cellular Toxicology (2025) Vol. 21, Iss. 2, pp. 387-397
Open Access
G.-H. An, Jinyeop Song, Wei Ying, et al.
Molecular & Cellular Toxicology (2025) Vol. 21, Iss. 2, pp. 387-397
Open Access
An overview and pathophysiology of liver diseases
Savneet Kaur, Dinesh Mani Tripathi
Elsevier eBooks (2025), pp. 1-42
Closed Access
Savneet Kaur, Dinesh Mani Tripathi
Elsevier eBooks (2025), pp. 1-42
Closed Access
Leveraging sodium alginate - nickel oxide - berbamine hybrid nanomaterials (HNMs) by assessing the cytotoxicity-mediated oxidative stress in Hep3B cell lines
K. Saravanan, Kalpana Sukumar, Muruganantham Bharathi, et al.
Process Biochemistry (2025)
Closed Access
K. Saravanan, Kalpana Sukumar, Muruganantham Bharathi, et al.
Process Biochemistry (2025)
Closed Access
On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular Carcinoma
Branislav Radjenović, Martin Sabo, Lukáš Šoltés, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5784-5784
Open Access | Times Cited: 30
Branislav Radjenović, Martin Sabo, Lukáš Šoltés, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5784-5784
Open Access | Times Cited: 30
Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis
Wenbin Liu, Yang Deng, Zishuai Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30
Wenbin Liu, Yang Deng, Zishuai Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 30
Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
Aswathy R. Devan, K Pavithran, Bhagyalakshmi Nair, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 36, pp. 5250-5264
Open Access | Times Cited: 19
Aswathy R. Devan, K Pavithran, Bhagyalakshmi Nair, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 36, pp. 5250-5264
Open Access | Times Cited: 19
BTEAC Catalyzed Ultrasonic-Assisted Synthesis of Bromobenzofuran-Oxadiazoles: Unravelling Anti-HepG-2 Cancer Therapeutic Potential through In Vitro and In Silico Studies
Ali Irfan, Ameer Fawad Zahoor, Azhar Rasul, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3008-3008
Open Access | Times Cited: 12
Ali Irfan, Ameer Fawad Zahoor, Azhar Rasul, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3008-3008
Open Access | Times Cited: 12
Bioinformatics and network pharmacology-based study to elucidate the multi-target pharmacological mechanism of the indigenous plants of Medina valley in treating HCV-related hepatocellular carcinoma
Mubarak A. Alamri
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 1125-1138
Open Access | Times Cited: 11
Mubarak A. Alamri
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 1125-1138
Open Access | Times Cited: 11
